Biotech Values

[drbio45]

benlysta is jumping off of the shelves


According to the NDC monthly sales data published by Wolters Kluwer, Benlysta posted $4.63M sales in the month of June. Adding sales data from April to June from the NDC database, we arrive at $7.37M for 2Q sales of Benlysta. Of note, the NDC data most likely under-reports the sales since a substantial portion of Benlysta is directly shipped from HGSI to infusion sites.


When HGSI reports 2Q results tomorrow after close, we will not be surprised if Benlysta meets or beats the Street consensus of $8.6M.